Skip to main content
Delfa

← All assets

PF-04360365

7 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.

Trials

7

Ongoing

0

Recruiting

0

Completed

7

Sites

71

Countries

8

Endpoints

225

Composite endpoints

0

Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 225 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.

Development

Where the program stands

Trials by phase

Phase 1
5
Phase 2
2

Trials by status

Completed
7

Evidence coverage

What this asset has been measured on

Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.

Safety / tolerability / PK
114
Amyloid biomarkers
43
Fluid / digital biomarkers
35
Neuroimaging
10
Global cognition
8
Function / daily living
6
Other (unclassified)
5
Tau biomarkers
4

Most-measured metrics

Top 20 metrics across this asset's endpoints

Normalized metric codes are available for 8 of 225 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.

ADAS-CogCognition

6

Mini-Mental State Examination (MMSE)Cognition

2

Trials

Trials for this asset

Every trial for this asset, with the same search, filters, and sort as the Trials tab.

7 of 7

Alzheimer’s disease and related dementias trials
Asset / Disease areaKey I/E criterionEvidence
NCT00722046Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

PF-04360365

Alzheimer’s disease

Alzheimer's diseasePh 2Completed42Aug 2011-results
NCT00455000A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

PF-04360365

Alzheimer’s disease

Alzheimer's diseasePh 1Completed12Sep 2009-
NCT00607308A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

PF-04360365

Alzheimer’s disease

Alzheimer's diseasePh 1Completed9Oct 20101
NCT00945672A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

PF-04360365

Alzheimer’s disease

Alzheimer's diseasePh 2Completed4Jun 2011-results
NCT01125631Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

PF-04360365

Alzheimer’s disease

Alzheimer's diseasePh 1Completed4Aug 2011-
NCT00733642Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

PF-04360365

Alzheimer’s disease

Alzheimer's diseasePh 1Completed3Jul 2009-
NCT01005862Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

PF-04360365

Alzheimer’s disease

Alzheimer's diseasePh 1Completed3Sep 2012-

Showing 1-7 of 7 trials